Cite
Integration of 60,000 exomes and ACMG guidelines question the role of Catecholaminergic Polymorphic Ventricular Tachycardia-associated variants.
MLA
Paludan, Müller, C., et al. “Integration of 60,000 Exomes and ACMG Guidelines Question the Role of Catecholaminergic Polymorphic Ventricular Tachycardia-Associated Variants.” Clinical Genetics, vol. 91, no. 1, Jan. 2017, pp. 63–72. EBSCOhost, https://doi.org/10.1111/cge.12847.
APA
Paludan, M. C., Ahlberg, G., Ghouse, J., Herfelt, C., Svendsen, J. H., Haunsø, S., Kanters, J. K., & Olesen, M. S. (2017). Integration of 60,000 exomes and ACMG guidelines question the role of Catecholaminergic Polymorphic Ventricular Tachycardia-associated variants. Clinical Genetics, 91(1), 63–72. https://doi.org/10.1111/cge.12847
Chicago
Paludan, Müller, C., G. Ahlberg, J. Ghouse, C. Herfelt, J.H. Svendsen, S. Haunsø, J.K. Kanters, and M.S. Olesen. 2017. “Integration of 60,000 Exomes and ACMG Guidelines Question the Role of Catecholaminergic Polymorphic Ventricular Tachycardia-Associated Variants.” Clinical Genetics 91 (1): 63–72. doi:10.1111/cge.12847.